ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

ADIL Adial Pharmaceuticals Inc

1.65
0.04 (2.48%)
최종 업데이트: 04:24:30
15분 지연
기업명 주식 심볼 시장 주식 타입
Adial Pharmaceuticals Inc ADIL 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.04 2.48% 1.65 04:24:30
개장가 저가 고가 종가 전일 종가
1.60 1.60 1.7499 1.61
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
22/04/202421:30GLOBEAdial Pharmaceuticals Granted Key Patent from the United..
10/04/202421:30GLOBEAdial Pharmaceuticals Announces Peer-Reviewed Publication..
02/04/202421:30GLOBEAdial Pharmaceuticals Reports 2023 Fiscal Year Financial..
02/03/202409:00GLOBEAdial Pharmaceuticals Announces Exercise of Warrants for..
28/02/202423:30GLOBEAdial Pharmaceuticals Awarded New Patent from the United..
15/02/202405:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/02/202423:15GLOBEAdial Pharmaceuticals Awarded New Patent Notice of Allowance..
26/01/202406:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/01/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
19/01/202406:15EDGAR2Form 8-K - Current report
18/01/202422:30GLOBEAdial Announces Appointment of Tony Goodman as Chief..
17/01/202406:17EDGAR2Form 8-K - Current report
13/01/202406:51EDGAR2Form S-3 - Registration statement under Securities Act of..
20/12/202323:00GLOBEAdial Pharmaceuticals Receives Final Reimbursement Payment..
13/12/202306:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/12/202301:08EDGAR2Form DEF 14A - Other definitive proxy statements
30/11/202306:47EDGAR2Form 8-K - Current report
30/11/202306:05GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
29/11/202306:10EDGAR2Form 8-K - Current report
24/11/202323:24EDGAR2Form PRE 14A - Other preliminary proxy statements
20/11/202321:46EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/11/202307:02GLOBEAdial Pharmaceuticals Reports Third Quarter 2023 Financial..
09/11/202306:05EDGAR2Form S-1 - General form for registration of securities under..
06/11/202320:14EDGAR2Form 8-K - Current report
31/10/202321:30GLOBEAdial Pharmaceuticals Chief Medical Officer and Key Opinion..
31/10/202306:24EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
31/10/202306:18EDGAR2Form 8-K/A - Current report: [Amend]
31/10/202306:17EDGAR2Form NT 10-Q/A - Notification of inability to timely file..
25/10/202321:00GLOBEAddiction Experts Highlight the Need for..
25/10/202305:48EDGAR2Form 8-K - Current report
25/10/202305:30GLOBEAdial Pharmaceuticals Announces Closing of $4 Million..
20/10/202321:00GLOBEAdial Pharmaceuticals Announces $4 Million Private Placement..
19/10/202323:30GLOBEAdial Pharmaceuticals Awarded Notice of Allowance for Key..
18/10/202321:00GLOBEAdial Pharmaceuticals Wins Frost & Sullivan's 2023 North..
03/10/202321:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/09/202320:00GLOBEAdial Pharmaceuticals to Host a Virtual Key Opinion Leader..
27/09/202310:08EDGAR2Form 8-K - Current report
22/09/202305:10EDGAR2Form 8-K - Current report
11/09/202319:03EDGAR2Form 8-K - Current report
05/09/202321:30GLOBEAdial Pharmaceuticals to Present at the H.C. Wainwright 25th..
28/08/202321:30GLOBEAdial Pharmaceuticals Chief Medical Officer and Key Opinion..
23/08/202321:45EDGAR2Form 8-K - Current report
23/08/202321:30GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
21/08/202321:46EDGAR2Form 8-K - Current report
21/08/202321:30GLOBEAdial Pharmaceuticals Reports Second Quarter 2023 Financial..
21/08/202321:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
19/08/202306:05EDGAR2Form 8-K - Current report
15/08/202319:01EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
04/08/202321:30EDGAR2Form 8-K - Current report
04/08/202321:30GLOBEAdial Pharmaceuticals Announces Reverse Stock Split to..

최근 히스토리

Delayed Upgrade Clock